Cancer cases are globally on the rise, causing an increasing demand for their treatment. Highly Potent Active Pharmaceutical Ingredients (hAPIs) are the key compounds for chemotherapies, combination therapies in particular.
Heraeus Pharmaceutical Ingredients is specialized in the production of generic hAPIs as well as the exclusive synthesis of cytotoxic compounds from research stage to market launch.
Heraeus Pharmaceutical Ingredients has developed a range of generic pharmaceutical ingredients for cancer therapy. The high purity of our hAPIs guarantees our customers effective processes and consistent top quality for their products. Continuous enhancement of our knowledge enables our customers to maintain compliance with changing regulations and ensures a long-term drug supply.
Learn more about our highly potent APIs
Many highly active ingredients require special handling, compelling manufacturers to take appropriate protective measures. Heraeus Pharmaceutical Ingredients with its broad experience in chemistry, processes and the appropriate equipment is a partner fully dedicated to the manufacturing of hAPIs. We support our customers in the exclusive synthesis of cytotoxic compounds from research stage to registration and market launch.
More than 35 years of expertise in the field of cytotoxic hAPIs is the foundation of our exclusive contract development and manufacturing services.
Learn more about our CDMO services
